Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
21/04/2026
New York spot gold fell below $4810 per ounce, down 0.39% intraday.
Latest
6 m ago
The CEO of Volkswagen has stated that the company may reduce its production capacity by as many as 1 million vehicles.
7 m ago
Crystal Optoelectronics: The development cycle for filter products used in optical communications is relatively short, and it is expected that a small amount of sales contribution will be made within the year.
11 m ago
Inner Mongolia: Strive to cultivate and form three trillion-level industry clusters by the end of the "15th Five-Year Plan".
12 m ago
Recently, the National Medical Products Administration approved the conditional marketing authorization of the innovative drug, Atezolizumab (trade name: Atesinuo), submitted by Bayer HealthCare Pharmaceuticals Inc. through the priority review process. The drug is indicated as a monotherapy for the treatment of unresectable locally advanced or metastatic non-small cell lung cancer (NSCLC) in adult patients with HER2 (ERBB2) mutations who have received at least one prior systemic therapy. The marketing of this drug provides patients with a new treatment option. (National Medical Products Administration)
15 m ago
COFCO Group and China National Cereals, Oils and Foodstuffs Corporation sign a strategic cooperation framework agreement.
See all latest